Mahzad Akbarpour to Immunotherapy
This is a "connection" page, showing publications Mahzad Akbarpour has written about Immunotherapy.
Connection Strength
0.156
-
Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy. Front Immunol. 2023; 14:1155778.
Score: 0.053
-
SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. Front Immunol. 2023; 14:1174138.
Score: 0.053
-
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives. Expert Rev Clin Immunol. 2022 Dec; 18(12):1217-1237.
Score: 0.050